Atea Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | — | — | $15.0M |
| FY2018 | — | — | $34.5M |
| FY2019 | $2.5M | $22.1M | $21.7M |
| FY2020 | $315.8M | $863.6M | $850.1M |
| FY2021 | $62.8M | $772.9M | $764.4M |
| FY2022 | $26.1M | $666.7M | $188.5M |
| FY2023 | $39.8M | $595.0M | $143.8M |
| FY2024 | $25.8M | $464.7M | $64.7M |
| FY2025 | $39.8M | $315.2M | $95.7M |